Gambia vs Madagascar: Access to anti-retroviral drugs, male
Gambia
27.0%
in 2024
Madagascar
22.0%
in 2024
Gambia rank
136th
Madagascar rank
139th
Access to anti-retroviral drugs, male over time
- Gambia
- Madagascar
How they compare
Gambia currently reports 27.0% against 22.0% in Madagascar, a difference of 5.0%.
That makes Gambia's figure about 1.2 times Madagascar's.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Madagascar ahead.
Gambia ranks 136th and Madagascar ranks 139th of 141 countries.
Gambia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Gambia | Madagascar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.4% | 0.4% | 1.0% | Gambia |
| 2010s | 12.2% | 3.4% | 8.8% | Gambia |
| 2020s | 22.2% | 15.0% | 7.2% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Gambia or Madagascar?
- Gambia, at 27.0% against 22.0% in Madagascar as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Gambia and Madagascar?
- 5.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Madagascar?
- 25 years are reported by both, from 2000 to 2024.
- How do Gambia and Madagascar rank globally for access to anti-retroviral drugs, male?
- Gambia ranks 136th and Madagascar ranks 139th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.